Dr. Forest Platt Walker, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Cave Run Cir, Versailles, KY 40383 Phone: 859-533-8038 |
Dr. Robert Zion Joseph, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Amsden Ave, Versailles, KY 40383 Phone: 859-873-3111 |
Dr. Jeffrey Edwards Holmberg, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 Amsden Ave, Versailles, KY 40383 Phone: 859-873-3111 |
Dr. Vicki Lynn Hawes, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 Amsden Ave, Versailles, KY 40383 Phone: 859-873-3111 |
Dr. Carter B Carr, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 Amsden Ave, Versailles, KY 40383 Phone: 859-873-3111 |
Brian A Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 Wilson Ave, First Floor, Versailles, KY 40383 Phone: 859-879-0111 Fax: 859-879-0363 |
News Archive
The cornea is a transparent tissue lining the front of the eye, that is invisible tissue to the naked eye. It is a delicate tissue and disease or injury may lead to a loss of transparency or a change in the shape of the cornea, resulting in severe visual impairment.
A survey reveals that the need for kidney transplants and dialysis is expected to soar by 2020 mainly due to a rise in diabetics developing chronic kidney disease and needing treatment. The total number of Australians being treated for end-stage kidney disease is forecast to rise by up to 80 per cent to about 4300 in the coming decade. While the fact that Australia's population is ageing and growing means more people are likely to develop end-stage kidney disease, the number of diabetics with the condition is also on the rise.
Alcohol-related liver disease (ALD) is a deadly condition affecting more than 150 million people worldwide with no treatment available besides transplant.
The Drugs for Neglected Diseases initiative has been awarded US$ 10 million by the United States Agency for International Development to develop new treatments for onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) - the first-ever USAID grant for neglected tropical disease research and development (R&D).
› Verified 3 days ago